DSE:ADVENT

Advent Pharma Ltd. announcements

129 Dhaka Stock Exchange announcements for Advent Pharma Ltd. (ADVENT) since 2018: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2018 (18).

  1. Q1 Financials

    (Q1 Un-audited): EPS was Tk. 0.61 for July-September, 2018 as against Tk. 0.24 for July-September, 2017; NOCFPS was Tk. 0.80 for July-September, 2018 as against Tk. 0.62 for July-September, 2017. NAV per share was Tk. 13.35 as on September 30, 2018 and Tk. 12.74 as on June 30, 2018

  2. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2018 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2018.

  3. Resumption after Record Date

    Trading of the shares of the Company will resume on 12.11.2018 after record date.

  4. Updating Information

    The Company has requested the shareholders to update their 12 digits e-TIN number and Bank details including Bank account number, Bank & Branch Name, routing number, mailing address and mobile number in the BO Accounts through their respective DPs before the record date. If anyone fails to update the e-TIN information; Income Tax at source will be deducted from the entitled dividend @ 15% instead of 10% (Cont.) (Continuation news of ADVENT): as per Section 54 of the amended Income Tax Ordinance, 1984 and also requested to update the Bank accounts details, so that the Company can credit the cash dividend through BEFTN. The Company has also requested to update their e-mail addresses for sending soft copies of the annual reports and notice to the shareholders. (end)

  5. Suspension for Record Date

    Trading of the shares of the Company will remain suspended on record date i.e., 11.11.2018.

  6. Spot News

    Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 07.11.2018 to 08.11.2018. Trading of the shares of the Company will remain suspended on record date i.e., 11.11.2018.

  7. Credit Rating Result

    Alpha Credit Rating Limited (AlphaRating) has rated the Company as "BBB+" in the long term and "ST-3" in the short term along with a stable outlook based on audited financial statements of the Company as on June 30, 2018 and relevant qualitative information up to November 05, 2018.

  8. Change of AGM date and time

    The Company has further informed that due to unavoidable circumstances the 11th AGM will now be held on 06.12.2018 at 10:00 AM instead of earlier declared date 05.12.2018 at 10:30 AM. Other information will remain unchanged.

  9. Dividend Declaration

    The Board of Directors has recommended 2% cash and 10% stock dividend for the year ended on June 30, 2018. Date of AGM: 5.12.2018, Time: 10:30 AM, Venue: Suchona Community Centre Limited, Ring Road, Mohammadpur, Dhaka-1207. Record Date: 11.11.2018. The Company has also reported EPS of Tk. 1.59, NAV per share of Tk. 12.74 and NOCFPS of Tk. 2.02 for the year ended on June 30, 2018 as against Tk. 1.49 (restated), Tk. 12.45 and Tk. 1.26 respectively for the same period of the previous year.

  10. Price Limit Open

    There will be no price limit on the trading of the shares of the Company today (21.10.2018) following its corporate declaration.

  11. Appointment of Chairman & Managing Director

    The Company has informed that Mr. Shafiqul Alam has been appointed as the Chairman of the board and Mr. Wajhi Ahmed as the Managing Director of the Company, with effect from October 15, 2018.

  12. Board Meeting schedule under LR 19(1)

    As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 18, 2018 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2018.

  13. Query Response

    In response to a DSE query dated July 11, 2018, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike of shares.

  14. Q3 Financials

    (Q3 Un-audited): EPS was Tk. 0.33 for January-March 2018 as against Tk. 0.33 for January-March 2017; EPS was Tk. 0.98 for July 2017-March 2018 as against Tk. 1.24 for July 2016-March 2017. NOCFPS was Tk. 1.80 for July 2017-March 2018 as against Tk. 1.07 for July 2016-March 2017. NAV per share was Tk. 12.46 as on March 31, 2018 and Tk. 12.45 as on June 30, 2017.

  15. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 26, 2018 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2018.

  16. Trading of New Security

    Trading of the shares of Advent Pharma Limited will commence at DSE from today i.e. April 12, 2018 under 'N' category. DSE Trading Code for Advent Pharma Limited is "ADVENT" and DSE Company Code is 18492.

  17. Prohibition on providing loan facilities to purchase securities

    DSE NEWS: The Stock Brokers, Merchant Bankers and Portfolio Managers are requested to abstain from providing loan facilities to purchase securities of Advent Pharma Limited in between 1st to 30th trading day starting from today (April 12, 2018) as per BSEC Directive No. SEC/CMRRCD/2009-193/177 and BSEC Order No. SEC/CMRRCD/2009-193/178 dated October 27, 2015.

  18. Q2 Financials

    (Q2 Un-audited): The Company has reported its profit after tax of Tk. 15.30 million and basic EPS of Tk. 0.31 for the 3 (three) months period ended on 31 December 2017 (October-December, 2017) as against profit after tax of Tk. 10.00 million and basic EPS of Tk. 0.58 for the same period of the previous year. It is to be noted that (cont. 1) (Continuation news of ADVENT): and 17,193,641 in 2016. However, considering Post-IPO 68,600,000 number of shares, Company's b basic EPS would be Tk. 0.46 for 6 (six) months period ended on 31 December 2017, (July-December, 2017) and NAV per share would be Tk. 12.20 as on 31 December, 2017. (end) (Continuation news of ADVENT): profit after tax was Tk. 31.65 million and basic EPS was Tk. 0.65 as against profit after tax of Tk. 17.99 million and basic EPS of Tk. 1.05 for the same period of the previous year. It is to be noted that the said EPS has been calculated based on weighted average Pre-IPO paid-up number of shares 48,600,000 in 2017 (cont. 3) (Continuation news of ADVENT): basic EPS has been calculated based on weighted average Pre-IPO paid-up number of shares 48,600,000 in 2017 and 17,193,641 in 2016. However, considering Post-IPO 68,600,000 number of shares the Company's basic EPS for the 3 (three) months period ended on 31 December, 2017 would be Tk. 0.22. For the 6 (six) months period (July- December, 2017) ended on 31 December, 2017 (cont. 2)

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.